Ray Dirks
Contributor since: 2012
Wize Pharma To Disrupt $3.7 Billion Dry Eye Market With High Efficacy, Low Cost Product
Pareteum: Levering Its Cloud Communications Platform To Serve $5 Billion Predictive Analytics Market
My Size’s Measurement Technology Uses Big Data To Solve Big Problem Of Apparel Returns, Further Boosting eCommerce Market
Dario’s Disruptive Digital Health Technology Upends Healthcare With Better Patient-Centric Method Of Treating Chronic Disease
Pareteum Powers Smart Cities, Improving Quality Of Life And Addressing Trillion Dollar Market Opportunity
TapImmune’s Cancer Vaccine Significantly Extends Progression Free Survival In Ovarian Cancer
Pareteum’s Mobility Cloud Platform Enables Blockchain Cryptocurrencies Worldwide
Can-Fite Lands $9,000,000-Plus Distribution Deal For Its Lead Drug In 3 European Countries
Pareteum Is The Next Twilio
Look To CEL-SCI To Deliver Phase III Results In 2018 For Worldwide Approval Of Head & Neck Cancer Immunotherapy
OTI Enters Bitcoin Market: Will Process Bitcoin At Physical Retailers Around The World
Can-Fit's Phase III Rheumatoid Arthritis Drug To Make CAR-T Cancer Therapies Safe & Effective
Rexahn To Give Celgene A Boost With New Combination Trial
U.S. Senate's National Defense Authorization Act Gives Pentagon The Power To Immediately Approve Pluristem's ARS Antidote
Stem Cell Industry Inflection Point Is Standardization And Cellect Has The Solution
U.S. Department Of Defense Turns To Pluristem For Preemptive Radiation Antidote As North Korea Threats Escalate
Nano-Inks & 3D Printing By Nano Dimension Accelerate Electronic Engineering
Pluristem’S Radiation Antidote Addresses $11 Billion Hematologic Indication In Human Trials
Health & Wellness Products Innovator TechCare Forges Alliance With Distribution Powerhouse HoMedics
Cellect's Novel Technology Isolates Therapeutic Stem Cells For Regenerative Medicine
Fast Food's Adoption Of Self-Serve Cashless Kiosks Means Fast Revenue For OTI In $18 Billion Market
$54 Billion Boost In U.S. Defense Budget Comes As Pluristem's Radiation Antidote Nears FDA Approval
The Public Health Crisis: Chronic Wounds Cost Lives And $50 Billion Annually
TapImmune's T-Cell Cancer Vaccine For Worldwide Eradication Of Women's Cancers
60 Minutes, Eli Lilly, Biogen, And Neurotrope, What A Story!
Breakthrough Oral Human Anti-CD3 Monoclonal Antibody For Treatment Of NASH And Autoimmune Disease At Tiziana Life Sciences
Allergan's $1.7 Billion Acquisition Of Tobira For NASH Drug Sets 1750% Potential Premium On Can-Fite Stock
Phase III Cell Therapy Company Pluristem Gets $8 Million Grant For Pivotal Trial In $12 Billion CLI Market
Gartner's Payments Industry Prediction: In The Next 2 Years 50% Of Consumers Will Pay With Wearable Devices Or Smartphones
Can-Fite Catapults NASH Indication Into Phase II Aiming For $35 Billion Market
Credit Suisse Reports: We Will Soon Live In A Cashless Society